BioIntegrator is a Russian biotech company engaged in the development and production of drugs based on recombinant proteins and other macromolecules.
Among the current projects of BioIntegrator there are both generic and original innovative drugs of their own design, based on increasing the cytotoxic effect of antitumor antibodies due to conjugation with small molecules. The technological and intellectual base of the company allows to carry out a full cycle of development and production: from growing the producer and biosynthesis of the target product to bottling the finished product. The manufacturing license allows a wide range of substances and injectable drugs.
BioIntegrator’s production site is more than 1500 sq. m., of which 700 sq. m. are clean rooms built according to the GMP standards.